Prima Plastics (530589)
Slow GrowerScore breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹180.4 |
| Market Cap | ₹198.45 Cr |
| P/E Ratio | 7.12 |
| ROCE | 13.1% |
| ROE | 12.1% |
| Dividend Yield | 1.66% |
| Profit Growth | 53.33% |
| Debt/Equity | — |
| Sales Growth | 3.61% |
| 52-Week Range | ₹88 — ₹180.4 |
| Sector | Consumer Durables |
| Book Value | ₹68.58 |
Strengths
- Low P/E of 7.12 and PEG of 0.25 suggest the market is pricing in little growth, offering potential value if earnings are sustained.
- Piotroski F-Score of 7/9 indicates solid financial health and improving fundamentals.
- ROE of 12.1% and ROCE of 13.1% show acceptable capital efficiency.
- Dividend yield of 1.66% provides a modest income cushion.
- Stock at its 52-week high shows renewed investor confidence after the profit jump.
Concerns
- Sales growth is only 3.61%, so the 53.33% profit growth may be from margin expansion or one-off gains rather than durable demand.
- P/B of 2.63 means paying over 2.6 times book value for a 12% ROE, leaving limited asset-based margin of safety.
- Latest quarter net profit of ₹5 Cr on ₹53 Cr sales, if annualised, may not fully support the trailing P/E of 7.12.
- Debt/Equity and promoter holding are not disclosed, making it difficult to assess balance-sheet risk and governance.
AI Analysis
Prima Plastics looks like a small, unglamorous consumer plastics company. At ₹180.40, the market cap is only ₹198 Cr, and the stock trades at 7.12 times trailing earnings. That is a low price for a business earning a 12.1% return on equity and 13.1% return on capital employed. The Piotroski F-Score of 7 is respectable and suggests recent fundamentals are not deteriorating. But I have to be honest: I don't see a wide moat here. Sales grew only 3.61%, so this is not a strong growth franchise. The 53.33% profit growth is exciting at first glance, and a PEG of 0.25 would make any value investor pause, but the latest quarter's ₹5 Cr net profit on ₹53 Cr sales makes me cautious about whether margins can be sustained. The company is quoting at its 52-week high, so Mr Market has noticed the earnings bounce. On a price-to-book basis, I'm paying 2.63 times book value – not obviously cheap for a 12% ROE. The 1.66% dividend yield offers a little income, but not enough if growth stalls. As Graham said, the margin of safety lies in facts, not hopes. I need clarity on debt and promoter holding; those data are missing. I'd classify this as a slow grower with a possible earnings turnaround. I would wait for stronger sales growth and proof that the profit jump is durable before committing much capital. A fair price for a mediocre grower is not the same as a wonderful purchase.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer